New Delhi/IBNS: Within hours after Prime Minister Narendra Modi launched the Covid-19 vaccination drive, the resident doctors of Delhi on Saturday preferred to be inoculated with Oxford vaccine, named Covishield in India, over the indigenous Covaxin.
Guwahati/UNI: The Covid-19 vaccination drive started in Assam on Saturday along with other parts of the country.
New Delhi/IBNS: Prime Minister Narendra Modi on Saturday launched the world's biggest Covid-19 vaccination drive in India, which is one of the worst Novel Coronavirus-hit countries.
New Delhi/IBNS: Prime Minister Narendra Modi will launch the pan India rollout of COVID-19 vaccination drive on Jan 16 at 10:30 AM via video conferencing.
New Delhi/IBNS: Prime Minister Narendra Modi is likely to inaugurate the coronavirus vaccination drive virtually on January 16, said media reports.
New Delhi/IBNS: Congress leader Manish Tewari has raised questions over unavailability of options in choosing the Coronavirus vaccine, according to media reports.
Hyderabad/IBNS: A day after the Serum Institute of India (SII) rolled out its vaccine against Covid-19, the first batch of India's indigenous remedy Covaxin, made by Bharat Biotech, left Hyderabad for 11 cities on Wednesday morning, media reports said.
New Delhi/IBNS: The Indian government on Tuesday said that no recipient of Covid-19 vaccine gets to choose from the two candidates available in the country for emergency use.
New Delhi/UNI: Bharat Biotech on Thursday announced that it has enrolled 25,800 volunteers for phase 3 clinical trials of its indigenously manufactured Covid-19 vaccine, 'Covaxin'.
New Delhi/IBNS: The Centre on Tuesday informed that Covid-19 vaccines will be ready for rollout in 10 days from the emergency use authorisation date based on feedback from the dry run.
New Delhi/IBNS: Chairman of Bharat Biotech- whose coronavirus vaccine Covaxin has been permitted for "restricted use in an emergency situation in public interest"- on Monday hit out at its critics and said 'don't accuse us of inexperience.'
New Delhi/IBNS: India registered 18,177 fresh infections in the last 24 hours taking the total Coronavirus cases to 1,03,23,965 on Sunday, the Union Health Ministry data showed.
New Delhi/IBNS: Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.
New Delhi/IBNS: Two Covid-19 vaccine candidates in India-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-now awaits the approval of the Drugs Controller General of India (DCGI) for emergency use after they have been cleared by the government-appointed panel.
New Delhi/IBNS: A government-appointed panel of experts on Saturday cleared emergency use of indigenous COVID-19 vaccine Covaxin manufactured by Hyderabad-based Bharat Biotech, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).